These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19107230)

  • 1. A quantitative volumetric micro-computed tomography method to analyze lung tumors in genetically engineered mouse models.
    Haines BB; Bettano KA; Chenard M; Sevilla RS; Ware C; Angagaw MH; Winkelmann CT; Tong C; Reilly JF; Sur C; Zhang W
    Neoplasia; 2009 Jan; 11(1):39-47. PubMed ID: 19107230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of mouse pulmonary cancer models by microcomputed tomography imaging.
    Fushiki H; Kanoh-Azuma T; Katoh M; Kawabata K; Jiang J; Tsuchiya N; Satow A; Tamai Y; Hayakawa Y
    Cancer Sci; 2009 Aug; 100(8):1544-9. PubMed ID: 19459854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of a MEK inhibitor at sub-MTD with a PI3K/mTOR inhibitor significantly suppresses growth of lung adenocarcinoma tumors in Kras(G12D-LSL) mice.
    Simmons BH; Lee JH; Lalwani K; Giddabasappa A; Snider BA; Wong A; Lappin PB; Eswaraka J; Kan JL; Christensen JG; Shojaei F
    Cancer Chemother Pharmacol; 2012 Aug; 70(2):213-20. PubMed ID: 22684718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of PHA-848125, a cyclin-dependent kinase inhibitor, on the K-Ras(G12D)LA2 lung adenocarcinoma transgenic mouse model: evaluation by multimodality imaging.
    Degrassi A; Russo M; Nanni C; Patton V; Alzani R; Giusti AM; Fanti S; Ciomei M; Pesenti E; Texido G
    Mol Cancer Ther; 2010 Mar; 9(3):673-81. PubMed ID: 20197397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model.
    Moghaddam SJ; Li H; Cho SN; Dishop MK; Wistuba II; Ji L; Kurie JM; Dickey BF; Demayo FJ
    Am J Respir Cell Mol Biol; 2009 Apr; 40(4):443-53. PubMed ID: 18927348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent.
    Badea CT; Athreya KK; Espinosa G; Clark D; Ghafoori AP; Li Y; Kirsch DG; Johnson GA; Annapragada A; Ghaghada KB
    PLoS One; 2012; 7(4):e34496. PubMed ID: 22485175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma.
    Kasinski AL; Slack FJ
    Cancer Res; 2012 Nov; 72(21):5576-87. PubMed ID: 22964582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF is an important mediator of tumor angiogenesis in malignant lesions in a genetically engineered mouse model of lung adenocarcinoma.
    Majeti BK; Lee JH; Simmons BH; Shojaei F
    BMC Cancer; 2013 Apr; 13():213. PubMed ID: 23627488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas.
    Tran PT; Fan AC; Bendapudi PK; Koh S; Komatsubara K; Chen J; Horng G; Bellovin DI; Giuriato S; Wang CS; Whitsett JA; Felsher DW
    PLoS One; 2008 May; 3(5):e2125. PubMed ID: 18461184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of pre-malignant lesions in a KRAS
    Rakhit CP; Trigg RM; Le Quesne J; Kelly M; Shaw JA; Pritchard C; Martins LM
    Dis Model Mech; 2019 Feb; 12(2):. PubMed ID: 30760495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer.
    Lee JW; Zhang Y; Eoh KJ; Sharma R; Sanmamed MF; Wu J; Choi J; Park HS; Iwasaki A; Kaftan E; Chen L; Papadimitrakopoulou V; Herbst RS; Koo JS
    J Thorac Oncol; 2019 Jun; 14(6):1046-1060. PubMed ID: 30771521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer.
    Fendrich V; Sparn M; Lauth M; Knoop R; Plassmeier L; Bartsch DK; Waldmann J
    Pancreatology; 2013; 13(5):502-7. PubMed ID: 24075515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth.
    Houghton AM; Rzymkiewicz DM; Ji H; Gregory AD; Egea EE; Metz HE; Stolz DB; Land SR; Marconcini LA; Kliment CR; Jenkins KM; Beaulieu KA; Mouded M; Frank SJ; Wong KK; Shapiro SD
    Nat Med; 2010 Feb; 16(2):219-23. PubMed ID: 20081861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KLF5 mediates the hyper-proliferative phenotype of the intestinal epithelium in mice with intestine-specific endogenous K-Ras
    Nandan MO; Bialkowska AB; Yang VW
    Am J Cancer Res; 2018; 8(4):723-731. PubMed ID: 29736317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.
    Shin J; Lee JC; Baek KH
    Cancer Lett; 2014 Jan; 342(1):70-81. PubMed ID: 24051307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mouse models for human colorectal cancer with liver metastasis].
    Huang XD; Zheng YB; Yang YJ; Yang C; Li HL; Cheng HR
    Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(34):2701-2705. PubMed ID: 31505723
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapamycin prevents early onset of tumorigenesis in an oral-specific K-ras and p53 two-hit carcinogenesis model.
    Raimondi AR; Molinolo A; Gutkind JS
    Cancer Res; 2009 May; 69(10):4159-66. PubMed ID: 19435901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
    Wang Y; Zhang Z; Lubet RA; You M
    Oncogene; 2006 Feb; 25(8):1277-80. PubMed ID: 16247444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.
    Belmont L; Rabbe N; Antoine M; Cathelin D; Guignabert C; Kurie J; Cadranel J; Wislez M
    Int J Cancer; 2014 Feb; 134(4):765-77. PubMed ID: 23913633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging primary lung cancers in mice to study radiation biology.
    Kirsch DG; Grimm J; Guimaraes AR; Wojtkiewicz GR; Perez BA; Santiago PM; Anthony NK; Forbes T; Doppke K; Weissleder R; Jacks T
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):973-7. PubMed ID: 20206017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.